Effectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine

Sadeleştirilmiş öğe sayfası
dc.contributor.authorIlgaz Aydinlar, Elif
dc.contributor.authorErdogan Soyukibar, Tuba
dc.contributor.authorYalinay Dikmen, Pinar
dc.date.accessioned2025-10-16T15:13:05Z
dc.date.issued2024
dc.identifier.doi10.3389/fneur.2024.1411238
dc.identifier.otherWOS:001248987100001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5746
dc.publisherFRONTIERS MEDIA SA
dc.sourceFRONTIERS IN NEUROLOGY
dc.subjectmigraine
dc.subjectgalcanezumab
dc.subjectsleep quality
dc.subjectmigraine outcome
dc.subjectMIDAS
dc.subjectHIT\\-6
dc.subjectquality of life
dc.subjectanxiety\\-depression
dc.titleEffectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS